供体MHC II类同种抗体在长期冷缺血小鼠肾移植中诱导肾小球损伤
该研究利用MHC不匹配小鼠肾移植模型,比较0.5小时与6小时冷缺血对移植物病理及供体反应性免疫的影响。结果发现6小时冷缺血增加抗MHC II类(而非I类)供体特异性抗体、供体反应性T细胞及巨噬细胞浸润肾小球,至60天出现广泛肾小球损伤。B细胞清除或FTY720抑制抗MHC II类抗体产生可阻断早期巨噬细胞浸润,提示MHC II类反应性供体特异性抗体是长期冷缺血所致肾小球损伤的关键介质。
要点
- 长期冷缺血增加抗MHC II类供体特异性抗体及肾小球巨噬细胞浸润。
- 抗MHC II类抗体是冷缺血相关肾小球损伤的关键介质。
- 抑制B细胞或FTY720可减少抗体产生和早期肾小球损伤。
核心结论
- 长期冷缺血后,移植后炎症增强针对MHC II类抗原的供体特异性抗体生成。
- MHC II类反应性供体特异性抗体是长期冷缺血所致肾同种移植物肾小球损伤的必要介质。
研究设计与样本
- 小鼠肾移植模型:将MHC不匹配的BALB/c肾同种移植物冷缺血保存0.5或6小时后移植入C57BL/6小鼠。
主要发现
- 移植后第14天,6小时较0.5小时冷缺血组抗MHC II类(而非I类)供体特异性抗体水平升高、供体反应性T细胞增多、巨噬细胞浸润肾小球比例显著更高。
- 移植后第60天,6小时冷缺血组出现广泛肾小球损伤,而0.5小时组仅中等病理。
- 病理与血清抗MHC II类(而非I类)供体特异性抗体水平升高相关。
- 受体B细胞清除阻断早期巨噬细胞募集,提示长期冷缺血后肾小球病理增加由增强的供体特异性抗体而非T细胞介导。
- FTY720特异性抑制抗MHC II类抗体产生并阻断巨噬细胞浸润肾小球;过继转移含抗供体MHC II类抗体的血清或抗供体MHC II类单克隆抗体可恢复FTY720处理受体的早期肾小球巨噬细胞浸润。
临床怎么用
- 在肾移植中,长期冷缺血可能通过诱导MHC II类供体特异性抗体促进肾小球损伤。
- 针对B细胞或MHC II类抗体产生的干预可能减轻冷缺血相关肾小球损伤。
局限性
- 研究为小鼠肾移植模型,结论外推至人类肾移植需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanisms underlying the effects of prolonged cold-ischemia storage on kidney allografts are poorly understood. METHODS: To investigate effects of cold ischemia on donor-reactive immune responses and graft pathology, we used a mouse kidney transplantation model that subjected MHC-mismatched BALB/c kidney allografts to cold-ischemia storage for 0.5 or 6 hours before transplant into C57BL/6 mice. RESULTS: At day 14 post-transplant, recipients of allografts subjected to 6 versus 0.5 hours of cold-ischemia storage had increased levels of anti-MHC class II (but not class I) donor-specific antibodies, increased donor-reactive T cells, and a significantly higher proportion of transplant glomeruli infiltrated with macrophages. By day 60 post-transplant, allografts with a 6 hour cold-ischemia time developed extensive glomerular injury compared with moderate pathology in allografts with 0.5 hour of cold-ischemia time. Pathology was associated with increased serum levels of anti-class 2 but not anti-class 1 donor-specific antibodies. Recipient B cell depletion abrogated early macrophage recruitment, suggesting augmented donor-specific antibodies, rather than T cells, increase glomerular pathology after prolonged cold ischemia. Lymphocyte sequestration with sphingosine-1-phosphate receptor 1 antagonist FTY720 specifically inhibited anti-MHC class II antibody production and abrogated macrophage infiltration into glomeruli. Adoptive transfer of sera containing anti-donor MHC class II antibodies or mAbs against donor MHC class II restored early glomerular macrophage infiltration in FTY720-treated recipients. CONCLUSIONS: Post-transplant inflammation augments generation of donor-specific antibodies against MHC class II antigens. Resulting MHC class II-reactive donor-specific antibodies are essential mediators of kidney allograft glomerular injury caused by prolonged cold ischemia.
引用
- Gorbacheva V, Fan R, Beavers A, et al. Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia. J Am Soc Nephrol. 2019. PMID: 31597715. doi:10.1681/ASN.2018111169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。